Skip to main content
SpringerLink
Log in

Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bennett MA, Heslop RW, Meynell MJ (1967) Massive haematuria associated with sickle-cell trait. Br Med J 1:677–679

    Article  CAS  PubMed  Google Scholar 

  2. Mostofi FK, Vorder Brueege CF, Diggs LW (1957) Lesions in kidneys removed for unilateral hematuria in sickle-cell disease. AMA Arch Pathol 63:336–351

    CAS  PubMed  Google Scholar 

  3. Lucas WM, Bullock WH (1960) Hematuria in sickle cell disease. J Urol 83:733–741

    CAS  PubMed  Google Scholar 

  4. Harrow BR, Sloane JA, Liebman NC (1963) Roentgenologic demonstration of renal papillary necrosis in sickle-cell trait. N Engl J Med 268:969–976

    Article  CAS  PubMed  Google Scholar 

  5. Immergut MA, Stevenson T (1965) The use of epsilon amino caproic acid in the control of hematuria associated with hemoglobinopathies. J Urol 93:110–111

    CAS  PubMed  Google Scholar 

  6. Charytan C, Purtilo D (1969) Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 280:1102–1104

    Article  CAS  PubMed  Google Scholar 

  7. Wellington K, Wagstaff AJ (2003) Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 63(13):1417–1433

    Article  CAS  PubMed  Google Scholar 

  8. Verstraete M (1985) Clinical application of inhibitors of fibrinolysis. Drugs 29(3):236–261

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland

    Niall F. Davis, Barry B. McGuire, Kiaran J. O’Malley & John M. Fitzpatrick

  2. Department of Radiology, Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland

    Leo Lawlor

  3. Department of Haematology, Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland

    Peter O’Gorman

Authors
  1. Niall F. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barry B. McGuire
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leo Lawlor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter O’Gorman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kiaran J. O’Malley
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John M. Fitzpatrick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Fitzpatrick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, N.F., McGuire, B.B., Lawlor, L. et al. Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease. Ann Hematol 89, 1179–1180 (2010). https://doi.org/10.1007/s00277-010-0936-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-010-0936-y

Keywords

Search

Navigation